跳至主要内容
临床试验/NCT01124578
NCT01124578已完成不适用

Validate the Acceptability of Egret's Extended Use Product as Compared to the Existing Daily Change-out Product

Egret Medical Products Inc.1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2008年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
200
试验地点
1
主要终点
Measure total aerobic bioburden levels after patient use

研究概览

简要总结

PURPOSE OF EVALUATION: This study will verify & validate the acceptability of Egret's extended use product as compared to the existing daily change-out product. Based on an extensive in-vitro study, Egret's product confirmed significant kill for both positive and negative gram bacteria. In addition to meeting all of the current product requirements, total aerobic bio-burden on the catheters will be tested at various intervals for up to 10 days of use. The current used product will be used as a control group that is to be changed out daily as per current policy. The control group will be tested for total aerobic bacteria counts on the last day of use.

详细描述

Protocol

Title: Extended Use In-line Endotracheal Suction Catheter w/BIOSAFE

Protocol Number: RT 2008-001

Study Director: Richard C. Dowdy

Study Director's Address and Method of Contact:

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients who agree to consent.

排除标准

  • Patients who do not agree to consent or with confirmed Ventilator-associated Pneumonia (VAP)are to be excluded from this study.

结局指标

主要结局

Measure total aerobic bioburden levels after patient use

时间窗: 1 to 10 days

Compare the average aerobic bio-burden level on the extended use Egret catheter to the existing used one day product after clinical use. The Egret catheter was used continuously for up to 10 days.

次要结局

  • Design Ease of Use(1-10 days)
  • No unexpected adverse events(1-10 days)

研究者

申办方类型
Industry

研究点 (1)

Loading locations...

相似试验